Cargando…
Epidermal Growth Factor Receptor Mutations and the Clinical Outcome in Male Smokers with Squamous Cell Carcinoma of Lung
Epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) have been reported to be related to certain clinical characteristics (i.e., female, non-smokers with adenocarcinoma) and gefitinib responsiveness. This exploratory analysis was performed to determine the incidenc...
Autores principales: | Park, Se Hoon, Ha, Seung Yeon, Lee, Jae-Ik, Lee, Hyewon, Sim, Hoyong, Kim, Young Saing, Hong, Junshik, Park, Jinny, Cho, Eun Kyung, Shin, Dong Bok, Lee, Jae Hoon |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2698191/ https://www.ncbi.nlm.nih.gov/pubmed/19543508 http://dx.doi.org/10.3346/jkms.2009.24.3.448 |
Ejemplares similares
-
Epidermal growth factor receptor mutation and pattern of brain metastasis in patients with non-small cell lung cancer
por: Baek, Min Young, et al.
Publicado: (2018) -
Pemetrexed versus Gefitinib versus Erlotinib in Previously Treated Patients with Non-Small Cell Lung Cancer
por: Hong, Junshik, et al.
Publicado: (2010) -
Prognostic Factors for Risk Stratification of Patients with Recurrent or Metastatic Pancreatic Adenocarcinoma Who Were Treated with Gemcitabine-Based Chemotherapy
por: Park, Inkeun, et al.
Publicado: (2016) -
Analysis of Fifty Hotspot Mutations of Lung Squamous Cell Carcinoma in Never-smokers
por: Lee, Ha Youn, et al.
Publicado: (2017) -
Baseline renal function as a prognostic indicator in patients with newly diagnosed diffuse large B-cell lymphoma
por: Hong, Junshik, et al.
Publicado: (2016)